Related Experiment Videos
Fluticasone inhibits but does not reverse allergen-induced structural airway changes
N J Vanacker1, E Palmans, J C Kips
1Department of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium. Nele.Vanacker@rug.ac.be
American Journal of Respiratory and Critical Care Medicine
|March 20, 2001
Summary
Fluticasone propionate (FP) partly inhibits airway remodeling and hyperresponsiveness in a rat asthma model when given during allergen exposure. However, post-hoc treatment does not reverse established airway remodeling.
Area of Science:
- Pulmonary Medicine
- Pharmacology
- Immunology
Background:
- Inhaled corticosteroids (ICS) are standard asthma treatment, but their effect on airway remodeling is not fully understood in humans due to ethical and technical limitations.
- Airway remodeling, characterized by structural changes, contributes to asthma severity and persistence.
- Animal models are crucial for investigating the impact of asthma therapies on airway remodeling.
Purpose of the Study:
- To evaluate the effect of fluticasone propionate (FP) on airway remodeling induced by allergen exposure in a rat model.
- To determine if FP can prevent the development of airway remodeling or reverse established changes.
Main Methods:
- Ovalbumin (OA)-sensitized rats were exposed to aerosolized OA.
- Animals received aerosolized fluticasone propionate (FP) or placebo either concurrently with OA exposure or after the exposure period.
- Airway wall remodeling, fibronectin deposition, epithelial changes, goblet cell hyperplasia, and airway hyperresponsiveness were assessed.
Main Results:
- OA challenge led to increased airway wall area, fibronectin deposition, epithelial cell proliferation, goblet cell hyperplasia, and airway hyperresponsiveness.
- Concomitant FP treatment partially inhibited these allergen-induced structural changes and hyperresponsiveness.
- FP treatment initiated after allergen exposure did not reverse established airway remodeling, although goblet cell hyperplasia resolved spontaneously.
Conclusions:
- Fluticasone propionate (FP) demonstrates a partial inhibitory effect on the development of structural airway changes and hyperresponsiveness in a rat model of asthma.
- FP is effective in preventing, but not reversing, established airway remodeling when administered during allergen exposure.
- These findings highlight the importance of early intervention with inhaled corticosteroids in managing asthma and preventing irreversible airway structural modifications.